CBS and bronchopulmonary dysplasia: Systemic targeting of H2S is a common limitation for highly encouraging studies demonstrating preclinical efficacy of H2S donors in experimental hyperoxic rodent models of BPD [9,133] and CBS and CSE promotion of perinatal alveolarization using whole-body knockout mice [8].